Macrogenics MGNX
NASDAQ MGNX
$4.39 +0.14 (+3.41%)
As of: Sep 4, 2026 · 3:15 PM EDT

Macrogenics (MGNX) Other Non-Current Assets (2012 - 2026)

Macrogenics (MGNX) posted quarterly Other Non-Current Assets of $1.4 million for Q1 2026, down 7.65% year-over-year from $1.5 million in Q1 2025, and down 0.65% quarter-over-quarter from $1.4 million in Q4 2025.

Analysis

Macrogenics (MGNX) Other Non-Current Assets (2012 - 2026) Analysis & Trends

Macrogenics (MGNX) has reported Other Non-Current Assets for 15 consecutive years, with $1.4 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Other Non-Current Assets fell 7.65% year-over-year to $1.4 million; the TTM figure through Mar 2026 stood at $1.4 million (down 7.65% YoY), while the FY2025 annual figure was $1.4 million, down 10.99% from the prior year.
  • Other Non-Current Assets fell to $1.4 million in Q1 2026 per MGNX's latest filing, from $1.4 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $17.2 million in Q1 2022 and bottomed at $1.2 million in Q1 2024.
  • Historically, Other Non-Current Assets has averaged $4.0 million across 5 years, with a median of $1.4 million in 2023.
  • Annual changes were most pronounced in 2023 — Other Non-Current Assets slumped 91.99% — and 2025, when it advanced 25.74%.
  • Macrogenics' Other Non-Current Assets stood at $1.4 million in 2022, then increased by 0.58% to $1.4 million in 2023, then grew by 12.27% to $1.6 million in 2024, then decreased by 10.99% to $1.4 million in 2025, then fell by 0.65% to $1.4 million in 2026.
  • Business Quant data shows MGNX's Other Non-Current Assets at $1.4 million in Q1 2026, $1.4 million in Q4 2025, and $1.4 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Vertex Pharmaceuticals 138.51 Bn 130.66 Bn 2.84 Bn 1.25 Bn
2 Regeneron Pharmaceuticals 85.24 Bn 77.25 Bn 3.93 Bn 2.31 Bn
3 Argenx Se 63.46 Bn 58.28 Bn 1.37 Bn 124.00 Mn
4 Moderna 57.89 Bn 52.75 Bn 52.00 Mn 618.00 Mn
5 Revolution Medicines 44.02 Bn 44.02 Bn - 42.45 Mn
6 BeOne Medicines 39.95 Bn 34.85 Bn 1.53 Bn 109.58 Mn
7 Alnylam Pharmaceuticals 35.49 Bn 32.19 Bn 992.69 Mn 65.13 Mn
8 Royalty Pharma 28.43 Bn 27.59 Bn - 62.96 Mn
9 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 104.44 Mn
10 Macrogenics 279.50 Mn 165.59 Mn - 195,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 195,000.00
Mar 31, 2026 1.38 Mn
Dec 31, 2025 22.38 Mn
Sep 30, 2025 1.39 Mn
Jun 30, 2025 1.40 Mn
Mar 31, 2025 1.49 Mn
Dec 31, 2024 1.56 Mn
Sep 30, 2024 1.19 Mn
Jun 30, 2024 1.19 Mn
Mar 31, 2024 1.19 Mn
Dec 31, 2023 1.39 Mn
Sep 30, 2023 1.39 Mn
Jun 30, 2023 1.39 Mn
Mar 31, 2023 1.38 Mn
Dec 31, 2022 1.38 Mn
Sep 30, 2022 15.54 Mn
Jun 30, 2022 16.39 Mn
Mar 31, 2022 17.21 Mn
Dec 31, 2021 1.40 Mn
Sep 30, 2021 18.78 Mn